

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.29729617 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.29729617 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.50453708 |
| 4 | actin-mediated cell contraction (GO:0070252) | 7.43832958 |
| 5 | skeletal muscle contraction (GO:0003009) | 7.12620418 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.10400120 |
| 7 | creatine metabolic process (GO:0006600) | 6.87933697 |
| 8 | sarcomere organization (GO:0045214) | 6.57934764 |
| 9 | skeletal muscle adaptation (GO:0043501) | 5.82522585 |
| 10 | myofibril assembly (GO:0030239) | 5.61286750 |
| 11 | actin filament-based movement (GO:0030048) | 5.48025217 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.30818582 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.24979894 |
| 14 | striated muscle contraction (GO:0006941) | 5.09268181 |
| 15 | plasma membrane repair (GO:0001778) | 5.00303681 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.99211241 |
| 17 | NADH metabolic process (GO:0006734) | 4.96487693 |
| 18 | carnitine shuttle (GO:0006853) | 4.84964418 |
| 19 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.79931157 |
| 20 | glycogen catabolic process (GO:0005980) | 4.66740155 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.66717258 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.55006859 |
| 23 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.54755286 |
| 24 | skeletal muscle tissue development (GO:0007519) | 4.48051409 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.39002925 |
| 26 | skeletal muscle fiber development (GO:0048741) | 4.38885741 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 4.36669995 |
| 28 | glucan catabolic process (GO:0009251) | 4.36577819 |
| 29 | fatty acid transmembrane transport (GO:1902001) | 4.32538541 |
| 30 | tricarboxylic acid cycle (GO:0006099) | 4.30689633 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.26930759 |
| 32 | heart contraction (GO:0060047) | 4.24981366 |
| 33 | heart process (GO:0003015) | 4.24981366 |
| 34 | response to inactivity (GO:0014854) | 4.24140562 |
| 35 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.21203418 |
| 36 | cardiac myofibril assembly (GO:0055003) | 4.18742404 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.16124104 |
| 38 | actomyosin structure organization (GO:0031032) | 4.13838303 |
| 39 | cellular polysaccharide catabolic process (GO:0044247) | 4.09448488 |
| 40 | fructose metabolic process (GO:0006000) | 4.09261038 |
| 41 | regulation of actin filament-based movement (GO:1903115) | 4.07078354 |
| 42 | axon ensheathment in central nervous system (GO:0032291) | 4.07048412 |
| 43 | central nervous system myelination (GO:0022010) | 4.07048412 |
| 44 | muscle hypertrophy (GO:0014896) | 4.06848329 |
| 45 | cardiac muscle contraction (GO:0060048) | 4.06079561 |
| 46 | negative regulation of protein localization to cell surface (GO:2000009) | 4.02375702 |
| 47 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.01448562 |
| 48 | adult heart development (GO:0007512) | 3.97498680 |
| 49 | muscle cell cellular homeostasis (GO:0046716) | 3.97256043 |
| 50 | muscle contraction (GO:0006936) | 3.95607601 |
| 51 | gluconeogenesis (GO:0006094) | 3.95325662 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 3.92529405 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 3.92529405 |
| 54 | cytidine metabolic process (GO:0046087) | 3.90732955 |
| 55 | cytidine catabolic process (GO:0006216) | 3.90732955 |
| 56 | cytidine deamination (GO:0009972) | 3.90732955 |
| 57 | polysaccharide catabolic process (GO:0000272) | 3.87066035 |
| 58 | striated muscle cell development (GO:0055002) | 3.86300026 |
| 59 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.85763847 |
| 60 | skeletal muscle tissue regeneration (GO:0043403) | 3.79756393 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.77265840 |
| 62 | muscle cell fate commitment (GO:0042693) | 3.76927631 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.76618626 |
| 64 | muscle organ morphogenesis (GO:0048644) | 3.75050203 |
| 65 | carnitine transmembrane transport (GO:1902603) | 3.74852020 |
| 66 | striated muscle atrophy (GO:0014891) | 3.73520722 |
| 67 | muscle structure development (GO:0061061) | 3.71274031 |
| 68 | muscle organ development (GO:0007517) | 3.70837288 |
| 69 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.69708857 |
| 70 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.69708857 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69579496 |
| 72 | purine nucleotide salvage (GO:0032261) | 3.68417248 |
| 73 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.66054366 |
| 74 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.66054366 |
| 75 | striated muscle adaptation (GO:0014888) | 3.65757677 |
| 76 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.65098555 |
| 77 | regulation of the force of heart contraction (GO:0002026) | 3.60363510 |
| 78 | myotube cell development (GO:0014904) | 3.59293574 |
| 79 | muscle system process (GO:0003012) | 3.58079424 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 3.56068542 |
| 81 | cardiac muscle adaptation (GO:0014887) | 3.54779211 |
| 82 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.54779211 |
| 83 | muscle hypertrophy in response to stress (GO:0003299) | 3.54779211 |
| 84 | hexose biosynthetic process (GO:0019319) | 3.54151544 |
| 85 | glycogen biosynthetic process (GO:0005978) | 3.49046798 |
| 86 | glucan biosynthetic process (GO:0009250) | 3.49046798 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.47714133 |
| 88 | positive regulation of myotube differentiation (GO:0010831) | 3.47625836 |
| 89 | regulation of sequestering of triglyceride (GO:0010889) | 3.46788470 |
| 90 | respiratory electron transport chain (GO:0022904) | 3.45862796 |
| 91 | amino-acid betaine transport (GO:0015838) | 3.40095511 |
| 92 | carnitine transport (GO:0015879) | 3.40095511 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.38840909 |
| 94 | electron transport chain (GO:0022900) | 3.33977052 |
| 95 | cellular carbohydrate catabolic process (GO:0044275) | 3.31919900 |
| 96 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31641258 |
| 97 | muscle cell development (GO:0055001) | 3.30714255 |
| 98 | cardiac muscle cell development (GO:0055013) | 3.30515311 |
| 99 | myoblast fusion (GO:0007520) | 3.29894385 |
| 100 | muscle fiber development (GO:0048747) | 3.26301206 |
| 101 | * response to activity (GO:0014823) | 3.26026329 |
| 102 | positive regulation of cation channel activity (GO:2001259) | 3.24952808 |
| 103 | fatty acid elongation (GO:0030497) | 3.23933060 |
| 104 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.23774415 |
| 105 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.19292287 |
| 106 | oxaloacetate metabolic process (GO:0006107) | 3.19264896 |
| 107 | relaxation of muscle (GO:0090075) | 3.18111948 |
| 108 | regulation of membrane repolarization (GO:0060306) | 3.18085865 |
| 109 | regulation of sulfur metabolic process (GO:0042762) | 3.16496695 |
| 110 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16302063 |
| 111 | myotube differentiation (GO:0014902) | 3.15772040 |
| 112 | muscle atrophy (GO:0014889) | 3.12695059 |
| 113 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.12412580 |
| 114 | muscle adaptation (GO:0043500) | 3.12100322 |
| 115 | oxidative phosphorylation (GO:0006119) | 3.11645855 |
| 116 | muscle tissue morphogenesis (GO:0060415) | 3.10112880 |
| 117 | regulation of lipoprotein metabolic process (GO:0050746) | 3.08509689 |
| 118 | mitochondrial fusion (GO:0008053) | 3.07050200 |
| 119 | membrane tubulation (GO:0097320) | 3.05552361 |
| 120 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.04448760 |
| 121 | response to mercury ion (GO:0046689) | 3.04015579 |
| 122 | cardiac cell development (GO:0055006) | 3.02302919 |
| 123 | glycogen metabolic process (GO:0005977) | 3.02292554 |
| 124 | ATP synthesis coupled proton transport (GO:0015986) | 2.99683524 |
| 125 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.99683524 |
| 126 | fatty acid beta-oxidation (GO:0006635) | 2.99306358 |
| 127 | regulation of sarcomere organization (GO:0060297) | 2.97393781 |
| 128 | glucan metabolic process (GO:0044042) | 2.96072695 |
| 129 | cellular glucan metabolic process (GO:0006073) | 2.96072695 |
| 130 | ubiquinone biosynthetic process (GO:0006744) | 2.95934958 |
| 131 | quinone biosynthetic process (GO:1901663) | 2.95934958 |
| 132 | striated muscle hypertrophy (GO:0014897) | 2.94369888 |
| 133 | cardiac muscle hypertrophy (GO:0003300) | 2.90734550 |
| 134 | * response to muscle activity (GO:0014850) | 2.88699032 |
| 135 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.87799711 |
| 136 | tissue regeneration (GO:0042246) | 2.87443663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.86817573 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.45373796 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.70263539 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.79813296 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.99102071 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.55481922 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.48643345 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46903341 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44733074 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.35507233 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.20172842 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.20172842 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.15883472 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15737800 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.15087803 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07882919 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05539335 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04221452 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92996777 |
| 20 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89054581 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88939360 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87122872 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.75268500 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.73372514 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72287943 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70488177 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70329210 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67793126 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64596018 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61291114 |
| 31 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.60980326 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58583764 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58252683 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52589204 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50818329 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48958904 |
| 37 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.46730949 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44931597 |
| 39 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43920762 |
| 40 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.42635104 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40051744 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39936778 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38201328 |
| 44 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.35405158 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35087712 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33488340 |
| 47 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33045208 |
| 48 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33009128 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32908399 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29987483 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28913921 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28095997 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27719907 |
| 54 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.27491907 |
| 55 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27135642 |
| 56 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26174087 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26132544 |
| 58 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.26096555 |
| 59 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25909674 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24177268 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23851194 |
| 62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23276091 |
| 63 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20215655 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18558231 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18227117 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17272000 |
| 67 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16411375 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15372865 |
| 69 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15055897 |
| 70 | MAF_26560356_Chip-Seq_TH1_Human | 1.14857124 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12825983 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12668421 |
| 73 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.12481937 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12185255 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12088283 |
| 76 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.11481773 |
| 77 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.09338209 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08926707 |
| 79 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.08356746 |
| 80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06467585 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05978431 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05084587 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04735183 |
| 84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04333031 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.04200513 |
| 86 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03760905 |
| 87 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03665481 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.03518345 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03208242 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01576783 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01483214 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01401212 |
| 93 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01292055 |
| 94 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.00924505 |
| 95 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00320440 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99857515 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99599149 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99547591 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99062296 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98417993 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97506310 |
| 102 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96586411 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96276025 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96099689 |
| 105 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95740426 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95063454 |
| 107 | P68_20966046_ChIP-Seq_HELA_Human | 0.94664058 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93858071 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92671783 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92322915 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91437986 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91047656 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91039720 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90854506 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90564759 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90344501 |
| 117 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89761756 |
| 118 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89350050 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89221718 |
| 120 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88737985 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88379915 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87191670 |
| 123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87165794 |
| 124 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86878351 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86847855 |
| 126 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.86439150 |
| 127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85467991 |
| 128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85387106 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85115587 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84761152 |
| 131 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84584485 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84330792 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84123997 |
| 134 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83805887 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82827139 |
| 136 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82054058 |
| 137 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81792204 |
| 138 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80497113 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80167304 |
| 140 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79655735 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.78203347 |
| 142 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.77651614 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.75227591 |
| 144 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.75125910 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75074862 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74362097 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74309931 |
| 148 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74309931 |
| 149 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73725232 |
| 150 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73446007 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71935102 |
| 152 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.70273554 |
| 153 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.69831377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.72746029 |
| 2 | MP0000749_muscle_degeneration | 5.39964633 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 5.14175150 |
| 4 | MP0000751_myopathy | 5.01622952 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.30890625 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.13868402 |
| 7 | MP0000747_muscle_weakness | 3.71283449 |
| 8 | MP0002106_abnormal_muscle_physiology | 3.34155533 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.09128971 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.96778254 |
| 11 | MP0004130_abnormal_muscle_cell | 2.93457637 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.87657608 |
| 13 | MP0002269_muscular_atrophy | 2.78521192 |
| 14 | MP0005369_muscle_phenotype | 2.70024504 |
| 15 | MP0005330_cardiomyopathy | 2.69687760 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.63148860 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.57254846 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.36546536 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.21227236 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.18295078 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.11280487 |
| 22 | MP0002972_abnormal_cardiac_muscle | 1.83142915 |
| 23 | MP0000920_abnormal_myelination | 1.79401993 |
| 24 | MP0009840_abnormal_foam_cell | 1.76305974 |
| 25 | MP0002332_abnormal_exercise_endurance | 1.74654523 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 1.72297508 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.62659598 |
| 28 | MP0004233_abnormal_muscle_weight | 1.58910677 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.58253136 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.53386791 |
| 31 | MP0000733_abnormal_muscle_development | 1.50973021 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.49467918 |
| 33 | MP0004484_altered_response_of | 1.47878733 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.46674046 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.45553575 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.40851743 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.40851743 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.40591803 |
| 39 | MP0000343_altered_response_to | 1.36331895 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.31981103 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.30653637 |
| 42 | MP0002971_abnormal_brown_adipose | 1.25667115 |
| 43 | MP0005083_abnormal_biliary_tract | 1.15678323 |
| 44 | MP0002108_abnormal_muscle_morphology | 1.14556271 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.12787451 |
| 46 | MP0005451_abnormal_body_composition | 1.11990400 |
| 47 | MP0001661_extended_life_span | 1.11761813 |
| 48 | MP0005266_abnormal_metabolism | 1.07515363 |
| 49 | MP0004147_increased_porphyrin_level | 1.07437018 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04299223 |
| 51 | MP0003828_pulmonary_edema | 1.04230159 |
| 52 | MP0003690_abnormal_glial_cell | 1.03772716 |
| 53 | MP0004510_myositis | 1.03359820 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.98409171 |
| 55 | MP0006138_congestive_heart_failure | 0.95915848 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 0.94484037 |
| 57 | MP0002822_catalepsy | 0.94345650 |
| 58 | MP0003195_calcinosis | 0.92341784 |
| 59 | MP0003329_amyloid_beta_deposits | 0.90605131 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 0.80701530 |
| 61 | MP0004043_abnormal_pH_regulation | 0.80071444 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.78991318 |
| 63 | MP0004085_abnormal_heartbeat | 0.77682292 |
| 64 | MP0003303_peritoneal_inflammation | 0.77152312 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.76000918 |
| 66 | MP0000604_amyloidosis | 0.73472741 |
| 67 | MP0004142_abnormal_muscle_tone | 0.72851941 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 0.71099392 |
| 69 | MP0001853_heart_inflammation | 0.70764336 |
| 70 | MP0002419_abnormal_innate_immunity | 0.69260244 |
| 71 | MP0003436_decreased_susceptibility_to | 0.67524886 |
| 72 | MP0003075_altered_response_to | 0.66627630 |
| 73 | MP0005165_increased_susceptibility_to | 0.65596109 |
| 74 | MP0004134_abnormal_chest_morphology | 0.61783560 |
| 75 | MP0009785_altered_susceptibility_to | 0.61758066 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 0.61145626 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.60661979 |
| 78 | MP0001851_eye_inflammation | 0.59404743 |
| 79 | MP0005025_abnormal_response_to | 0.58574937 |
| 80 | MP0003186_abnormal_redox_activity | 0.58559740 |
| 81 | MP0003045_fibrosis | 0.57450441 |
| 82 | MP0004270_analgesia | 0.57171527 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.56295174 |
| 84 | MP0005670_abnormal_white_adipose | 0.56137311 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.55616050 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.55298341 |
| 87 | MP0003879_abnormal_hair_cell | 0.54881157 |
| 88 | MP0005334_abnormal_fat_pad | 0.52531784 |
| 89 | MP0010030_abnormal_orbit_morphology | 0.52208242 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.51628409 |
| 91 | MP0000266_abnormal_heart_morphology | 0.51137180 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.50719976 |
| 93 | MP0008260_abnormal_autophagy | 0.50051954 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.49601664 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.49225375 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.48461529 |
| 97 | MP0008469_abnormal_protein_level | 0.47751651 |
| 98 | MP0002933_joint_inflammation | 0.47358653 |
| 99 | MP0005332_abnormal_amino_acid | 0.46970491 |
| 100 | MP0000685_abnormal_immune_system | 0.45731384 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.45638121 |
| 102 | MP0005464_abnormal_platelet_physiology | 0.44043343 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.43951375 |
| 104 | MP0008569_lethality_at_weaning | 0.43381998 |
| 105 | MP0005166_decreased_susceptibility_to | 0.43377869 |
| 106 | MP0001533_abnormal_skeleton_physiology | 0.43080621 |
| 107 | MP0000609_abnormal_liver_physiology | 0.41896738 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.41831807 |
| 109 | MP0008875_abnormal_xenobiotic_pharmacok | 0.41746367 |
| 110 | MP0006082_CNS_inflammation | 0.41500887 |
| 111 | MP0003724_increased_susceptibility_to | 0.41421566 |
| 112 | MP0005535_abnormal_body_temperature | 0.41071056 |
| 113 | MP0002128_abnormal_blood_circulation | 0.39358330 |
| 114 | MP0005452_abnormal_adipose_tissue | 0.34816925 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.33924106 |
| 116 | MP0005187_abnormal_penis_morphology | 0.33070994 |
| 117 | MP0009672_abnormal_birth_weight | 0.31042886 |
| 118 | MP0000762_abnormal_tongue_morphology | 0.30773220 |
| 119 | MP0003948_abnormal_gas_homeostasis | 0.28106322 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.28005370 |
| 121 | MP0002114_abnormal_axial_skeleton | 0.27055893 |
| 122 | MP0009250_abnormal_appendicular_skeleto | 0.24878141 |
| 123 | MP0005423_abnormal_somatic_nervous | 0.24822583 |
| 124 | MP0002734_abnormal_mechanical_nocicepti | 0.23789101 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.23486154 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.22552121 |
| 127 | MP0004924_abnormal_behavior | 0.22552121 |
| 128 | MP0002066_abnormal_motor_capabilities/c | 0.22248094 |
| 129 | MP0006276_abnormal_autonomic_nervous | 0.21489584 |
| 130 | MP0003011_delayed_dark_adaptation | 0.18898904 |
| 131 | MP0002234_abnormal_pharynx_morphology | 0.17695959 |
| 132 | MP0001943_abnormal_respiration | 0.16535792 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.16432682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.81622636 |
| 2 | Exercise-induced myalgia (HP:0003738) | 7.81381093 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.52833203 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.40199982 |
| 5 | Nemaline bodies (HP:0003798) | 7.08539054 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.62938477 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.15449964 |
| 8 | Muscle fiber splitting (HP:0003555) | 5.61757138 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 5.43448715 |
| 10 | Distal arthrogryposis (HP:0005684) | 5.30231768 |
| 11 | Myoglobinuria (HP:0002913) | 5.25237657 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.95308716 |
| 13 | Difficulty running (HP:0009046) | 4.95093546 |
| 14 | Myopathic facies (HP:0002058) | 4.67657701 |
| 15 | Round ear (HP:0100830) | 4.60300404 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.60161820 |
| 17 | Ulnar deviation of the wrist (HP:0003049) | 4.46869963 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.34503762 |
| 19 | Muscle stiffness (HP:0003552) | 4.34126872 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.19746522 |
| 21 | Calcaneovalgus deformity (HP:0001848) | 3.88672336 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.88564052 |
| 23 | Subaortic stenosis (HP:0001682) | 3.88564052 |
| 24 | Sudden death (HP:0001699) | 3.86070196 |
| 25 | Myotonia (HP:0002486) | 3.57764001 |
| 26 | Increased connective tissue (HP:0009025) | 3.56937814 |
| 27 | Deformed tarsal bones (HP:0008119) | 3.50087513 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.45435180 |
| 29 | Neck muscle weakness (HP:0000467) | 3.41181171 |
| 30 | Absent phalangeal crease (HP:0006109) | 3.24978206 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.24232694 |
| 32 | Ventricular tachycardia (HP:0004756) | 3.21023731 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.91235193 |
| 34 | Difficulty climbing stairs (HP:0003551) | 2.72546728 |
| 35 | Lipoatrophy (HP:0100578) | 2.69796979 |
| 36 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.66031167 |
| 37 | Areflexia of lower limbs (HP:0002522) | 2.61355512 |
| 38 | Frequent falls (HP:0002359) | 2.59956147 |
| 39 | Abnormal finger flexion creases (HP:0006143) | 2.59618119 |
| 40 | Rimmed vacuoles (HP:0003805) | 2.58762900 |
| 41 | Dilated cardiomyopathy (HP:0001644) | 2.53346690 |
| 42 | Gowers sign (HP:0003391) | 2.48215245 |
| 43 | Malignant hyperthermia (HP:0002047) | 2.46757555 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.43628390 |
| 45 | Fetal akinesia sequence (HP:0001989) | 2.31802705 |
| 46 | Weak cry (HP:0001612) | 2.30366637 |
| 47 | Paralysis (HP:0003470) | 2.25311594 |
| 48 | Hepatic necrosis (HP:0002605) | 2.24417246 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.19064385 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.14413617 |
| 51 | Hip contracture (HP:0003273) | 2.14407784 |
| 52 | Muscular dystrophy (HP:0003560) | 2.12418607 |
| 53 | Abnormality of the calcaneus (HP:0008364) | 2.12261362 |
| 54 | Generalized muscle weakness (HP:0003324) | 2.09733096 |
| 55 | Hyperkalemia (HP:0002153) | 2.08496405 |
| 56 | Atrial fibrillation (HP:0005110) | 2.07817253 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.07541562 |
| 58 | Spinal rigidity (HP:0003306) | 2.06293613 |
| 59 | Palpitations (HP:0001962) | 2.05516869 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.05399182 |
| 61 | Abnormality of the neuromuscular junction (HP:0003398) | 2.04025417 |
| 62 | Fatigable weakness (HP:0003473) | 2.04025417 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02840423 |
| 64 | Bulbar palsy (HP:0001283) | 2.02567400 |
| 65 | Cholelithiasis (HP:0001081) | 2.02455394 |
| 66 | EMG: neuropathic changes (HP:0003445) | 2.01199081 |
| 67 | Axonal loss (HP:0003447) | 2.00797221 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 2.00547071 |
| 69 | Waddling gait (HP:0002515) | 2.00266179 |
| 70 | Exercise intolerance (HP:0003546) | 1.99032290 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98753257 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 1.98226988 |
| 73 | Slender build (HP:0001533) | 1.95812663 |
| 74 | Abnormality of glycolysis (HP:0004366) | 1.94881379 |
| 75 | Increased serum pyruvate (HP:0003542) | 1.94881379 |
| 76 | Stridor (HP:0010307) | 1.94603887 |
| 77 | Limb-girdle muscle atrophy (HP:0003797) | 1.94496644 |
| 78 | Nonprogressive disorder (HP:0003680) | 1.94457074 |
| 79 | Facial diplegia (HP:0001349) | 1.93222244 |
| 80 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.92987135 |
| 81 | Foot dorsiflexor weakness (HP:0009027) | 1.92900518 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 1.92273167 |
| 83 | Acute encephalopathy (HP:0006846) | 1.91613005 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 1.89052161 |
| 85 | Scapular winging (HP:0003691) | 1.87314803 |
| 86 | Primary atrial arrhythmia (HP:0001692) | 1.87249825 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 1.86839076 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86839076 |
| 89 | Lower limb amyotrophy (HP:0007210) | 1.86393586 |
| 90 | Abnormality of the foot musculature (HP:0001436) | 1.84971787 |
| 91 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84659760 |
| 92 | Supraventricular tachycardia (HP:0004755) | 1.83794795 |
| 93 | Mitochondrial inheritance (HP:0001427) | 1.81950785 |
| 94 | Distal lower limb amyotrophy (HP:0008944) | 1.79850688 |
| 95 | Bundle branch block (HP:0011710) | 1.77499854 |
| 96 | Supraventricular arrhythmia (HP:0005115) | 1.77379114 |
| 97 | Ventricular arrhythmia (HP:0004308) | 1.70291502 |
| 98 | Hypoplastic ischia (HP:0003175) | 1.68500387 |
| 99 | Increased CSF lactate (HP:0002490) | 1.68308864 |
| 100 | Limb-girdle muscle weakness (HP:0003325) | 1.67313044 |
| 101 | Heart block (HP:0012722) | 1.65832483 |
| 102 | Cerebral edema (HP:0002181) | 1.65746932 |
| 103 | Lactic acidosis (HP:0003128) | 1.63833474 |
| 104 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.63758397 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 1.62587600 |
| 106 | Ketosis (HP:0001946) | 1.62532779 |
| 107 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.61121302 |
| 108 | Proximal amyotrophy (HP:0007126) | 1.59708077 |
| 109 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.59295999 |
| 110 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.59070514 |
| 111 | Shoulder girdle muscle weakness (HP:0003547) | 1.55060661 |
| 112 | Metatarsus adductus (HP:0001840) | 1.54018685 |
| 113 | Long clavicles (HP:0000890) | 1.52478540 |
| 114 | Popliteal pterygium (HP:0009756) | 1.52365038 |
| 115 | Pelvic girdle muscle weakness (HP:0003749) | 1.50140200 |
| 116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.48838535 |
| 117 | Ulnar deviation of finger (HP:0009465) | 1.44714280 |
| 118 | Limited hip movement (HP:0008800) | 1.44407568 |
| 119 | Oligomenorrhea (HP:0000876) | 1.38680479 |
| 120 | Muscle fiber atrophy (HP:0100295) | 1.38167886 |
| 121 | Ventricular fibrillation (HP:0001663) | 1.36046578 |
| 122 | Steppage gait (HP:0003376) | 1.35551560 |
| 123 | Atrioventricular block (HP:0001678) | 1.35389227 |
| 124 | Left ventricular hypertrophy (HP:0001712) | 1.31966731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.73815107 |
| 2 | TTN | 5.99384660 |
| 3 | PHKG1 | 4.64758746 |
| 4 | PHKG2 | 4.64758746 |
| 5 | PIK3CG | 2.80785149 |
| 6 | BCKDK | 2.64158221 |
| 7 | MAP2K3 | 2.61394152 |
| 8 | EPHB1 | 2.53174661 |
| 9 | MUSK | 2.51763917 |
| 10 | NME1 | 2.45960076 |
| 11 | PINK1 | 2.29379369 |
| 12 | STK39 | 2.00883203 |
| 13 | DMPK | 1.91495360 |
| 14 | TRIB3 | 1.79860050 |
| 15 | PDK3 | 1.69642851 |
| 16 | PDK4 | 1.69642851 |
| 17 | MAP3K7 | 1.58797330 |
| 18 | PKN2 | 1.48662198 |
| 19 | MAPK12 | 1.47160770 |
| 20 | MAPKAPK5 | 1.45844235 |
| 21 | PIK3CA | 1.44890205 |
| 22 | TRPM7 | 1.43936439 |
| 23 | PKN1 | 1.28947548 |
| 24 | NEK1 | 1.21186944 |
| 25 | MYLK | 1.20849808 |
| 26 | PDK2 | 1.11307471 |
| 27 | LIMK1 | 1.01110428 |
| 28 | MARK1 | 0.99171660 |
| 29 | ILK | 0.97723967 |
| 30 | KIT | 0.96996760 |
| 31 | STK24 | 0.95739981 |
| 32 | OXSR1 | 0.89789826 |
| 33 | MAP2K6 | 0.88319797 |
| 34 | FLT3 | 0.88239268 |
| 35 | PRKAA2 | 0.85736371 |
| 36 | CDK19 | 0.84796599 |
| 37 | CAMK2D | 0.79256921 |
| 38 | PRKD1 | 0.78288970 |
| 39 | ERN1 | 0.77404267 |
| 40 | DYRK1B | 0.77338456 |
| 41 | MAP4K1 | 0.76312895 |
| 42 | CAMK2G | 0.73836020 |
| 43 | NEK9 | 0.72359735 |
| 44 | MOS | 0.72249613 |
| 45 | TIE1 | 0.69656064 |
| 46 | ERBB3 | 0.68939838 |
| 47 | CCNB1 | 0.68288557 |
| 48 | MAP3K11 | 0.67889998 |
| 49 | CSF1R | 0.65936130 |
| 50 | ROCK2 | 0.65375742 |
| 51 | TBK1 | 0.64446358 |
| 52 | BTK | 0.64227715 |
| 53 | LRRK2 | 0.61652802 |
| 54 | MAP3K3 | 0.61640409 |
| 55 | CAMK4 | 0.60634992 |
| 56 | MAP2K4 | 0.59546854 |
| 57 | MAPK4 | 0.58529550 |
| 58 | GRK7 | 0.57711605 |
| 59 | MAPK7 | 0.56888075 |
| 60 | TGFBR2 | 0.54553932 |
| 61 | TYK2 | 0.54402955 |
| 62 | MAPKAPK3 | 0.53734180 |
| 63 | WNK1 | 0.52725125 |
| 64 | WNK4 | 0.52433299 |
| 65 | IRAK4 | 0.51797599 |
| 66 | BLK | 0.51231886 |
| 67 | PDPK1 | 0.51116704 |
| 68 | CAMK2A | 0.50728354 |
| 69 | MAPK11 | 0.49100437 |
| 70 | PRKAA1 | 0.47839975 |
| 71 | MAP2K1 | 0.47397526 |
| 72 | TEC | 0.46614543 |
| 73 | ROCK1 | 0.46301392 |
| 74 | NME2 | 0.44064798 |
| 75 | PRKACB | 0.43170083 |
| 76 | FES | 0.41303506 |
| 77 | PDK1 | 0.40830317 |
| 78 | LMTK2 | 0.40816574 |
| 79 | KDR | 0.40813564 |
| 80 | MAP3K1 | 0.40729535 |
| 81 | SGK3 | 0.40080684 |
| 82 | MAP3K13 | 0.39937349 |
| 83 | MET | 0.39264657 |
| 84 | ICK | 0.37360626 |
| 85 | CLK1 | 0.36294943 |
| 86 | PRKCQ | 0.35910117 |
| 87 | STK4 | 0.33110687 |
| 88 | SIK1 | 0.32616278 |
| 89 | DAPK3 | 0.32449831 |
| 90 | PRKG1 | 0.32113941 |
| 91 | MAPK13 | 0.31759364 |
| 92 | SGK2 | 0.31371853 |
| 93 | HCK | 0.28495238 |
| 94 | ITK | 0.28121423 |
| 95 | EEF2K | 0.27795820 |
| 96 | SGK1 | 0.27475921 |
| 97 | KSR2 | 0.27193152 |
| 98 | RPS6KA3 | 0.26625185 |
| 99 | RPS6KA6 | 0.26421672 |
| 100 | AKT2 | 0.26363349 |
| 101 | CAMK2B | 0.25882052 |
| 102 | PTK6 | 0.25856055 |
| 103 | STK16 | 0.25822411 |
| 104 | SYK | 0.25466633 |
| 105 | RPS6KB1 | 0.25026365 |
| 106 | PIM2 | 0.24025284 |
| 107 | RIPK1 | 0.24006270 |
| 108 | RPS6KB2 | 0.23681474 |
| 109 | PRKG2 | 0.22892991 |
| 110 | TAOK3 | 0.22568318 |
| 111 | RPS6KA1 | 0.22321365 |
| 112 | RPS6KC1 | 0.21953659 |
| 113 | RPS6KL1 | 0.21953659 |
| 114 | PRKACA | 0.21733000 |
| 115 | MAPKAPK2 | 0.21667123 |
| 116 | LATS2 | 0.21642846 |
| 117 | ABL2 | 0.21631999 |
| 118 | CAMK1 | 0.21624509 |
| 119 | CSNK1G3 | 0.21443629 |
| 120 | DAPK2 | 0.20576570 |
| 121 | MAP3K5 | 0.19676665 |
| 122 | JAK2 | 0.19414220 |
| 123 | MAPK10 | 0.18922467 |
| 124 | PRKACG | 0.18766292 |
| 125 | MAP3K6 | 0.18575013 |
| 126 | SGK223 | 0.16714320 |
| 127 | SGK494 | 0.16714320 |
| 128 | MAPK15 | 0.15947699 |
| 129 | INSRR | 0.13978034 |
| 130 | MARK2 | 0.11526093 |
| 131 | PAK3 | 0.11356555 |
| 132 | MTOR | 0.11132465 |
| 133 | STK11 | 0.11089863 |
| 134 | LATS1 | 0.10921926 |
| 135 | NLK | 0.09011228 |
| 136 | PTK2B | 0.08877612 |
| 137 | TAOK2 | 0.07979002 |
| 138 | MARK3 | 0.07442456 |
| 139 | EPHA3 | 0.06082178 |
| 140 | MAPK8 | 0.04844616 |
| 141 | RPS6KA2 | 0.04263924 |
| 142 | GSK3B | 0.03837694 |
| 143 | TNK2 | 0.03772119 |
| 144 | CDC42BPA | 0.03340674 |
| 145 | MAPK3 | 0.02504344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.17389600 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.34726915 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.33074215 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.15889905 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.09170159 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.80114055 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.72081154 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.69627709 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61939396 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51681774 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.46019005 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.37086575 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26322756 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.19216243 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.14476598 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13412913 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10027760 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97192568 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90933142 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83539128 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72690499 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.70125509 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.69331473 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.54856565 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54254866 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42093534 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40628677 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29965626 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28962170 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28178378 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24617966 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23306702 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.22297097 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21088456 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19409647 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.13773882 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06252721 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06084556 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02292509 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00944350 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.00113167 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94381858 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92140279 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88505246 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87042537 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86056388 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84097179 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83359453 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82243004 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81451222 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80939395 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80757340 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.75963750 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75169462 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.65634954 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64284005 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62959890 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61481062 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.59043171 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57612732 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.57358491 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56693673 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56445552 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56443354 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56054777 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55968907 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55933470 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55753602 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.55177248 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55146456 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51510451 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51103853 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48989717 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47499677 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47391420 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46629894 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45899706 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45021409 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44366535 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.43015650 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42700693 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41986533 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41496568 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41292991 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40699504 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40015741 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.38718529 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38226358 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37917362 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.37800081 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.36853586 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36319291 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35932985 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34209560 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34062550 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.33815890 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33041712 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.32987210 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32303216 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31523640 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.31411608 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31247270 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.30949858 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29866375 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29472818 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28060952 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28034375 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.26874365 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26449419 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25680608 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24927631 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.24256722 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23602275 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23017942 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21808700 |
| 116 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.21729806 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21385557 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19122494 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.18738221 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.18464478 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.18350270 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.17875088 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.16781565 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16680149 |
| 125 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15830171 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14900060 |
| 127 | Olfactory transduction_Homo sapiens_hsa04740 | 0.10675007 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.08119509 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07760687 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07306367 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.06615567 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03925868 |

